| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 155.06× | 155.06× | 149.52× | 163.49× | 159.30× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 4.73× | 4.08× | 4.11× | 5.97× | 3.48× | ||
| 0.78× | 0.78× | 0.76× | 0.70× | 0.65× | ||
| 0.91× | 0.91× | 0.85× | 2.26× | 1.33× | ||
| 0.50× | 0.50× | 0.48× | 1.20× | 0.66× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 159.30 | 163.49 | 149.52 | 155.06 | 155.06 | |
| Working Capital Turnover | 3.48 | 5.97 | 4.11 | 4.08 | 4.73 | |
| Asset Turnover | 0.65 | 0.70 | 0.76 | 0.78 | 0.78 | |
| Cash Conversion (CFO/Net Income) | 1.33 | 2.26 | 0.85 | 0.91 | 0.91 | |
| CFO/EBITDA | 0.66 | 1.20 | 0.48 | 0.50 | 0.50 |